Commercial testing of Descrete’s DP201 additive

Commercialisation Australia funding has been awarded to undertake laboratory testing and site trialling of Descrete’s cement additive, DP201, to ensure compatibility with a US partner’s existing manufacturing infrastructure and local raw materials.

A successful trial will lead to a Heads of Agreement in regards to the ongoing supply of DP201, moving to a full commercial supply arrangement.